Myriad Genetics | MYGN - Stock

Aktienkurs
4.68
Täglich Wechseln
0 0%
Monatlich
4.00%
Jährlich
-34.36%
Q2 Prognose
4.68




Stock Veränderung Datum
Agilent USD 1.06B 34M 2025-12
Becton, Dickinson and Co. USD 4.08B 191M 2025-12
Bio-Rad Laboratories USD 740.7M 42.5M 2025-12
Bruker USD 1.2B 21.7M 2025-09
Danaher USD 2.61B 119M 2026-03
Illumina USD 564M 26M 2025-12
J&J USD 14.58B 392M 2026-03
Mettler Toledo International USD 387.23M 14.58M 2025-12
Myriad Genetics USD 30.6M 1000K 2025-12
OraSure Technologies USD 31.06M 2.34M 2025-12
Pacific Biosciences Of California USD 49.28M 3.87M 2025-12
Quest Diagnostics USD 225M 36M 2026-03
Quidel USD 577.6M 36.2M 2025-12
Repligen USD 170.46M 10.14M 2025-12
Revvity USD 379.5M 420K 2025-12
Standard Biotools USD 19.98M 5.44M 2025-12
Thermo Fisher Scientific USD 5.5B 71M 2026-03
Veracyte USD 20.55M 219K 2025-12
Waters USD 572.37M 570K 2025-12